Huda Salman
Clinical trials sponsored by Huda Salman, explained in plain language.
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis early-stage trial tests a new treatment called CD4CAR T cells for people with chronic myelomonocytic leukemia (CMML) that has come back or not responded to standard care. The treatment uses a patient's own immune cells, modified in a lab to recognize and attack cancer cells.…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New immune cell therapy takes aim at Hard-to-Treat T-Cell cancers
Disease control Recruiting nowThis early-phase trial is testing a new type of immune therapy called CD4CAR for people with T-cell lymphoma or leukemia that has come back or not responded to treatment. The therapy uses a patient's own immune cells, which are modified in a lab to recognize and attack cancer cel…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Engineered immune cells aim to clear leukemia before transplant
Disease control Recruiting nowThis early-phase trial is testing a new type of CAR T-cell therapy, called CD4CAR, in people with acute myeloid leukemia (AML) that has come back or not responded to standard treatment. The therapy targets a protein called CD4 on leukemia cells. The goal is to safely eliminate as…
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC